Last reviewed · How we verify
NCT05642663
Observational Study of ALTUS Powered Stapler Used in Bariatric Surgery
trial testing Stapler in Obesity in 300 participants. Participants enrolled and being followed up; not accepting new ones.
30 July 2024
Quick facts
| Lead sponsor | Scitech Produtos Medicos SA |
|---|---|
| Status | Active, enrolled |
| Study type | OBSERVATIONAL |
| Enrollment | 300 |
| Start date | 31 May 2023 |
| Primary completion | 30 July 2024 |
| Estimated completion | 30 June 2025 |
| Sites | 1 location across Brazil |
Drugs / interventions tested
- Stapler
Conditions studied
- Obesity — all drugs for Obesity →
Sponsor
Scitech Produtos Medicos SA — full company profile →
Who can join
18 and older, any sex, with Obesity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Post-marketing, observational study to evaluate the safety and performance of the ALTUS Powered Stapler in bariatric surgery of "real-world" patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05642663
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Stapler
Trials testing the same drug.
- NCT05789459 — Comparison of Outcomes With Stapler Versus Hand-Sewn Closure After Minimally Invasive Distal Pancreatectomy · completed
- NCT03880773 — Comparison Between Two Methods of Pancreatic Transection in Distal Pancreatectomy · NA · unknown
- NCT02941640 — Influence of the Different Ways of Appendix Stump Closure on Patient Outcome in Laparoscopic Appendectomy · NA · completed
Other recruiting trials for Obesity
Currently open trials in the same condition.
- NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
- NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
- NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
- NCT07481630 — A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoart · Phase 3 · recruiting
- NCT07527195 — Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscl · Phase 1 · recruiting
Other Scitech Produtos Medicos SA trials
Trials by the same sponsor.
- NCT07491107 — Brazilian Prospective Registry of the Inspiron EVO Drug-Eluting Stent in Complex Coronary Lesions · not yet recruiting
- NCT03606629 — SOLARIS Endoprosthesis in Iliac Occlusive Disease · completed
- NCT03780192 — INSPIRON Sirolimus Eluting Stent Performance in Bifurcation Coronary Arteries Treated Using Provisional Technique · unknown
- NCT03471234 — Latin America Real World Study With Inspiron Drug Eluting Stent - INSPIRON LATITUDE · completed
- NCT03535610 — Uterine Artery Embolization With Microspheres in Patients With Leiomyoma. · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05642663 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Scitech Produtos Medicos SA
- Last refreshed: 5 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05642663.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing